Ensysce Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Ensysce Biosciences Inc.
- Former names
- Leisure Acquisition Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- La Jolla
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ENSC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001716947
- EIN
- 82-2755287
Board of directors
-
Bob G. Gower · DirectorSince 2023
-
James William Morrison · Director · PresidentSince 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $444,169
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Bob G. Gower Director | Open-market purchase | +400,000 | $0.50 | $198,000 |
| Apr 23, 2026 | Bob G. Gower Director | Open-market purchase | +508,614 | $0.48 | $246,169 |
| Mar 2, 2023 | Bob G. Gower Director | Open-market purchase | +90,287 | $0.49 | $44,241 |
| Mar 1, 2023 | Bob G. Gower Director | Open-market purchase | +270,000 | $0.48 | $129,600 |
| Feb 28, 2023 | Bob G. Gower Director | Open-market purchase | +109,300 | $0.49 | $53,557 |
| Dec 9, 2022 | Bob G. Gower Director | Open-market purchase | +357,143 | $1.40 | $500,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.